Dopamine receptor antagonists fail to prevent induction of cocaine sensitization

Neuropsychopharmacology

Volumn 18, Issue 1, 1998, Pages 26-40

  White, Francis J ^a   Joshi, Amit ^a   Koeltzow, Timothy E ^a   Hu, Xiu Ti ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Behavioral sensitization; Cocaine; Dopamine D1 receptors; Dopamine D2 receptors; Nucleus accumbens; Ventral tegmental area

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ETICLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG SENSITIZATION; DRUG WITHDRAWAL; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREVENTION; PRIORITY JOURNAL; RAT; SUPERSENSITIVITY;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; COCAINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SALICYLAMIDES;

EID: 0031950688     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00093-6     Document Type: Article

References (68)

1. Badiani A, Browman KE, Robinson TE Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res. 674:1995;291-298.
2. Beninger RJ, Herz RS Pimozide blocks establishment but not expression of cocaine-induced environment-specific conditioning. Life Sci. 38:1986;1425-1431.
3. 1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther. 277:1996;1177-1187.
4. Bradberry CW Microdialysis assessment of the impact of (+)3,4-methylenedioxymethamphetamine, cocaine, and cocaethylene on serotonergic neurons. Drug Dev Res. 33:1994;1-9.
5. Cass WA, Zahniser NR Cocaine levels in striatum and nucleus accumbens. Augmentation following challenge injection in rats withdrawn from repeated cocaine administration Neurosci Lett. 152:1993;177-180.
6. Cervo L, Samanin R Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats. Brain Res. 731:1996;31-38.
7. Creese I, Chen A Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. Eur J Pharmacol. 109:1985;127-128.
8. 2 receptor-mediated behavior and on extracellular concentrations of serotonin and dopamine Pharmacol Biochem Behav. 49:1994;107-113.
9. 2-dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior. Behav Pharmacol. 4:1993;375-387.
10. 2 dopamine antagonist with amphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546:1991;40-46.
11. Heidbreder CA, Thompson AC, Shippenberg TS Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther. 278:1996;490-502.
12. Henry DJ, Greene MA, White FJ Electrophysiological effects of cocaine in the mesoaccumbens dopamine system. repeated administration J Pharmacol Exp Ther. 251:1989;833-839.
13. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther. 258:1991;882-890.
14. Henry DJ, White FJ The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci. 15:1995;6287-6299.
15. 2 receptor selective antagonists. Electrophysiological and behavioral studies Synapse. 17:1994;43-61.
16. Kalivas PW Neural basis of behavioral sensitization to cocaine. Hammer RP Jr. The Neurobiology of Cocaine. Cellular and Molecular Mechanisms:1995;81-98 CRC Press, Boca Raton, FL.
17. Kalivas PW, Duffy P Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 13:1993;266-275.
18. Kalivas PW, Stewart J Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev. 16:1991;223-224.
19. Karler R, Calder LD, Chaudhry IA, Turkanis SA Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
20. Karler R, Calder LD, Bedingfield JB Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology (Berl). 115:1994;305-310.
21. Koeltzow TE, Joshi A, Hu X-T, Wolf ME, White FJ (1997): Dopamine receptor antagonists and the induction of sensitization to cocaine and amphetamine. Soc Neurosci Abst 23 (in press).
22. Koob GF Drugs of abuse. anatomy, pharmacology and function of reward pathways Trends Pharmacol Sci. 13:1992;177-184.
23. Kuczenski R, Leith NJ Chronic amphetamine. Is dopamine a link in or a mediator of the development of tolerance and reverse tolerance? Pharmacol Biochem Behav. 15:1981;405-413.
24. Kuczenski R, Segal DS Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci. 9:1989;2051-2065.
25. 1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice. Pharmacol Biochem Behav. 52:1995;759-763.
26. 2 receptor antagonists in terms of ambulation in mice. Pharmacol Biochem Behav. 51:1995;799-805.
27. Kuribara H Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol. Psychopharmacology (Berl). 119:1995;34-38.
28. Kuribara H, Uchihashi Y Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J Pharm Pharmacol. 45:1993;1042-1045.
29. Kuribara H, Uchihashi Y Effects of dopamine antagonism on methamphetamine sensitization. Evaluation by ambulatory activity in mice Pharmacol Biochem Behav. 47:1994;101-106.
30. Martin-Iverson MT, Reimer AR Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats. Psychopharmacology (Berl). 114:1994;315-320.
31. 2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology (Berl). 114:1994;239-242.
32. Mattingly BA, Rowlett JK, Ellison T, Rase K Cocaine-induced behavioral sensitization. Effects of haloperidol and SCH 23390 treatments Pharmacol Biochem Behav. 53:1996;481-486.
33. 1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitisation following repeated administration of cocaine Neuropharmacology. 32:1993;387-391.
34. McGonigle P, Boyson SJ, Reuter S, Molinoff PB Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 3:1989;74-82.
35. Parsons LH, Koob GF, Weiss F Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther. 274:1995;1182-1191.
36. Pettit HO, Pan H-T, Parsons LH, Justice JB Jr. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem. 55:1990;798-804.
37. Post RM Intermittent versus continuous stimulation. Effect of time interval on the development of sensitization or tolerance Life Sci. 26:1980;1275-1282.
38. Post RM, Weiss SRB, Pert A Sensitization and kindling effects of chronic cocaine administration. Lakoski JM, Galloway MP, White FJ Cocaine. Pharmacology, Physiology and Clinical Strategies:1992;115-161 CRC Press, Boca Raton, FL.
39. Post RM, Contel NR Human and animal studies of cocaine. Implications for development of behavioral pathology Creese I Stimulants. Neurochemical, Behavioral and Clinical Perspectives:1983;169-203 Raven Press, New York.
40. Reimer AR, Martin-Iverson MT Nimodipine and haloperidol attenuate behavioral sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion by cocaine. Psychopharmacology. 113:1994;404-410.
41. Reith MEA, Benuck M, Lajtha A Cocaine disposition in the brain after continuous or intermittent treatment and locomotor stimulation in mice. J Pharmacol Exp Ther. 243:1987;281-287.
42. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
43. Robinson TE, Becker JB Enduring changes in brain and behavior produced by chronic amphetamine administration. A review and evaluation of animal models of amphetamine psychosis Brain Res Rev. 11:1986;157-198.
44. Robinson TE, Berridge KC The neural basis of drug craving. An incentive-sensitization theory of addiction Brain Res Rev. 18:1993;247-291.
45. Self DW, Nestler EJ Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci. 18:1995;463-495.
46. Shippenberg TS, Heidbreder C Sensitization to the conditioned rewarding effects of cocaine. Pharmacological and temporal characteristics J Pharmacol Exp Ther. 273:1995;808-815.
47. Stewart J, Badiani A Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol. 4:1993;289-312.
48. Stewart J, Vezina P Microinjections of SCH 23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495:1989;401-406.
49. Tella SR Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol Biochem Behav. 48:1994;151-159.
50. Tella SR Possible novel pharmacodynamic action of cocaine. Cardiovascular and behavioral evidence Pharmacol Biochem Behav. 54:1996;343-354.
51. Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology. 98:1989;89-92.
52. Ujike H, Kuroda S, Otsuki S σ receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol. 296:1996;123-128.
53. 2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol Biochem Behav. 52:1995;737-741.
54. 4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
55. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci. 16:1996;2411-2420.
56. Vezina P, Stewart J The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499:1989;108-120.
57. 2 Dopamine Receptor Interactions. 1993;51-78 Academic Press, San Diego, CA.
58. Weiss F, Paulus MP, Lorang MT, Koob GF Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels. Effects of acute and repeated administration J Neurosci. 12:1992;4372-4380.
59. Weiss SRB, Post RM, Pert A, Woodward R, Murman D Context-dependent cocaine sensitization. Differential effect of haloperidol on development versus expression Pharmacol Biochem Behav. 34:1989;655-661.
60. White FJ, Hu X-T, Henry DJ Electrophysiological effects of cocaine in the rat nucleus accumbens. Microiontophoretic studies J Pharmacol Exp Ther. 266:1993;1075-1084.
61. White FJ, Hu X-T, Henry DJ, Zhang X-F Neurophysiological alterations in the mesocorticolimbic dopamine system during repeated cocaine administration. Hammer RP Jr. The Neurobiology of Cocaine. Cellular and Molecular Mechanisms:1995;95-115 CRC Press, Boca Raton, FL.
62. White FJ, Hu X-T, Zhang X-F, Wolf ME Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther. 273:1995;445-454.
63. White FJ Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci. 19:1996;405-436.
64. White FJ, Hu X-T, Zhang X-F Neuroadaptations in nucleus accumbens neurons resulting from repeated cocaine administration. Goldstein D, Eisenhofer G, McCarty R Catecholamines. Bridging Basic Science with Clinical Medicine:1998;1006-1009 Academic Press, San Diego, CA.
65. 2 Dopamine Receptor Interactions. 1993;79-114 Academic Press, San Diego, CA.
66. White FJ, Wolf ME Psychomotor stimulants. Pratt JA The Biological Basis of Drug Tolerance and Dependence. 1991;153-197 Academic Press, London.
67. Wise RA, Bozarth MA A psychomotor stimulant theory of addiction. Psychol Rev. 94:1987;469-492.
68. Wolf ME, Jeziorski M Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613:1993;291-294.